Related Organization(s)

You just read:

Launch of a strategic partnership between the IRCM and Nuclea Biotechnologies - A partnership to determine risk and progression of type 2 diabetes

News provided by

Institut de recherches cliniques de Montréal (IRCM)

Aug 11, 2015, 12:28 ET